Genetic Determination of Bronchopulmonary Dysplasia Formation: Pros and Cons

Genetic Determination of Bronchopulmonary Dysplasia Formation: Pros and Cons

Currently, researches are being actively carried out to identify genetic risk factors for the development of bronchopulmonary dysplasia (BPD) in premature infants, including genetic polymorphism encoding surfactants, matrix metalloproteinases, cytokines, growth factors, and components of the body’s...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. K. Pozharishchenskaya, I. V. Davydova, K. V. Savostianov, L. S. Namazova-Baranova, E. B. Pavlinova, A. V. Pushkov
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2017-05-01
Series:	Педиатрическая фармакология
Subjects:	premature infants bronchopulmonary dysplasia antioxidants surfactants cytokines metalloproteinases genetic polymorphism risk factors
Online Access:	https://www.pedpharma.ru/jour/article/view/1498
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bronchopulmonary Dysplasia in Post-Surfactant Era: Results of an Objective Assessment of the Disease
by: I. V. Davydova, et al.
Published: (2015-09-01)

Criteria for the duration of anti-inflammatory therapy in children with bronchopulmonary dysplasia
by: Т. І. Stepanenko, et al.
Published: (2019-04-01)

Efficacy of vibroacoustic therapy in treatment of pneumonia in children with bronchopulmonary dysplasia
by: Madina Syzdykova, et al.
Published: (2023-09-01)

Bronchopulmonary dysplasia in children: clinical and anamnestic aspects of cytokine gene polymorphisms
by: S. V. Suprun, et al.
Published: (2025-01-01)

Correlates of Elevated Interleukin-6 and 8-Hydroxy-2′-Deoxyguanosine Levels in Tracheal Aspirates from Very Low Birth Weight Infants Who Develop Bronchopulmonary Dysplasia
by: Chien-Chou Hsiao, et al.
Published: (2017-02-01)

Loss of Surfactant Protein A Alters Perinatal Lung Morphology and Susceptibility to Hyperoxia-Induced Bronchopulmonary Dysplasia
by: Shaili Amatya, et al.
Published: (2024-10-01)

Enhanced vs. standard low dose dexamethasone treatment on respiratory outcomes of preterm infants with bronchopulmonary dysplasia
by: Sezgin Gunes, et al.
Published: (2025-08-01)

Evaluation of mediators of fibrosis and angiogenesis in the blood serum of premature infants with bronchopulmonary dysplasia
by: E. L. Semikina, et al.
Published: (2023-06-01)

Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia
by: Minji Heo, et al.
Published: (2020-08-01)

A Practical, Evidence-Based Approach to Postneonatal Management of Children with Bronchopulmonary Dysplasia
by: Caroline Poulter, et al.
Published: (2019-07-01)

PREVENTIVE STRATEGIES IN THE STAGES OF FORMATION AND COURSE OF BRONCHOPULMONARY DYSPLASIA
by: I. V. Davydova, et al.
Published: (2014-03-01)

Primary Serological Status and Immunological Efficacy of Vaccination against Streptococcus Pneumoniae and Haemophilus Influenzae Type b in Children with Bronchopulmonary Dysplasia: a Cohort Study
by: Klavdiia A. Kazakova, et al.
Published: (2018-02-01)

Low serum IGF-1 and increased cytokine levels in tracheal aspirate samples are associated with bronchopulmonary dysplasia
by: Cansu Yılmaz, et al.
Published: (2017-04-01)

The Most Important Risk Factors and Associated Morbidities of Bronchopulmonary Dysplasia, the Never Ending Problem of Preterms
by: Ayşen Bayrak, et al.
Published: (2025-08-01)

Correlation analysis between patent ductus arteriosus and bronchopulmonary dysplasia in premature infants
by: Hao Luo, et al.
Published: (2025-08-01)

Predictors of bronchopulmonary dysplasia occurrence and severity in extremely preterm infants
by: Xuejing Liu, et al.
Published: (2025-08-01)

RISK FACTORS OF BRONCHOPULMONARY DYSPLASIA DEVELOPMENT IN NEONATES WITH VERY LOW AND EXTREMELY LOW BIRTH WEIGHT
by: O. V. Lebedeva
Published: (2014-05-01)

Decreased neutrophil levels in bronchopulmonary dysplasia infants
by: Xingchao Li, et al.
Published: (2020-12-01)

Extrapulmonary Conditions, Concomitant of Bronchopulmonary Dysplasia, in Babies of the First 3 Years of Life: Results of a Retrospective Cross-Sectional Study
by: K. A. Kazakova, et al.
Published: (2016-12-01)

Inhaled nitric oxide as an independent intervention to lower the risk of bronchopulmonary dysplasia in preterm infants (< 33 weeks) with pulmonary hypertension within the initial 3 days of life
by: Tasnim Azad, et al.
Published: (2025-07-01)

A Comparison of the 2022 Versus 2011 National Institute of Child Health and Human Development Web-Based Risk Estimator for Bronchopulmonary Dysplasia
by: Mitchell Kinkor, MD, et al.
Published: (2024-12-01)

The Impact of Atrial Left-to-Right Shunt on Pulmonary Hypertension in Preterm Infants with Moderate or Severe Bronchopulmonary Dysplasia
by: Eui Kyung Choi, et al.
Published: (2015-10-01)

Proteomic analysis of premature umbilical cord blood and its relationship with bronchopulmonary dysplasia
by: Jia Chen, et al.
Published: (2025-03-01)

Broncho-phonography as a method for predicting the outcome of respiratory distress syndrome in preterm infants
by: Ye. B. Pavlinova, et al.
Published: (2011-08-01)

Meta-analysis of budesonide and surfactant combination for the prevention of bronchopulmonary dysplasia in preterm neonates based on gestational age
by: Sedigheh Ekraminasab, et al.
Published: (2025-04-01)

Evaluation of melatonin efficacy in prevention of bronchopulmonary dysplasia in preterm newborn infants
by: Manizheh Mostafa Gharehbaghi, et al.
Published: (2022-02-01)

Association of TNF-α genetic variants with neonatal bronchopulmonary dysplasia: consolidated results
by: Seyedeh Elham Shams, et al.
Published: (2024-12-01)

Association between gastroesophageal reflux and bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis
by: XinYi Yu, et al.
Published: (2025-06-01)

Can the Oxygen Saturation Index Predict Severe Bronchopulmonary Dysplasia?
by: Hulya Ozdemir, et al.
Published: (2025-04-01)

Bronchopulmonary Dysplasia: a Modern View on Course and Outcomes
by: K. A. Kazakova
Published: (2016-11-01)

Application broncho-phonography investigation for an estimation of respiratory frustration at immature infants with a respiratory distress-syndrome
by: Ye. B. Pavlinova, et al.
Published: (2010-06-01)

Trends in bronchopulmonary dysplasia and 15-year evolution in respiratory and hemodynamic management of very premature infants
by: Juan Antonio Costa Orvay, et al.
Published: (2025-07-01)

Respiratory Syncytial Virus Lower Respiratory Tract Infections in Premature Infants and Infants with Bronchopulmonary Dysplasia
by: D. Yu. Ovsyannikov, et al.
Published: (2015-10-01)

Characterization of gut microbiota in very low birth weight infants with versus without bronchopulmonary dysplasia
by: Anucha Thatrimontrichai, et al.
Published: (2025-07-01)

Comparative analysis of three bronchopulmonary dysplasia diagnostic criteria in predicting longterm neurodevelopmental outcomes in preterm infants
by: Rui Li, et al.
Published: (2025-08-01)

Development and external validation of a machine learning model to predict bronchopulmonary dysplasia using dynamic factors
by: Ho Jung Choi, et al.
Published: (2025-04-01)

Analysis and validation of necroptosis-related diagnostic biomarkers associated with immune infiltration in bronchopulmonary dysplasia
by: Haixia Tu, et al.
Published: (2025-07-01)

Delayed Dexamethasone Therapy and Neurodevelopmental Outcomes in Preterm Infants with Bronchopulmonary Dysplasia
by: Gina Lim, et al.
Published: (2015-08-01)

Clinical analysis and predictive value of early serum lipid levels in very premature and extremely preterm infants with bronchopulmonary dysplasia: a 4 years retrospective study
by: Zhenyu Xiong, et al.
Published: (2025-02-01)

Assessment of Safety, Immunogenicity and Preventive Efficacy of Prevenar-13 in Children with Bronchopulmonary Dysplasia
by: E. S. Zubova, et al.
Published: (2018-04-01)